MSP’s £60m Citylabs plans approved
Manchester Science Partnerships’ plans for a £60m investment in a two-phase expansion of its Citylabs biomedical campus has been approved by the city council.
Citylabs 2.0 and 3.0 will be delivered by Bruntwood on behalf of the joint venture between MSP with Central Manchester University Hospitals NHS Foundation Trust.
Designed by architects Sheppard Robson, and aimed at health and medical technology companies, the scheme will provide high-specification, flexible office, laboratory, and clinical space. It is located in Manchester’s innovation district, Corridor Manchester, which has enterprise zone status, meaning occupiers can access significantly reduced business rates and super-fast connectivity.
Manchester Science Partnerships’ plans for a £60m investment in a two-phase expansion of its Citylabs biomedical campus has been approved by the city council.
Citylabs 2.0 and 3.0 will be delivered by Bruntwood on behalf of the joint venture between MSP with Central Manchester University Hospitals NHS Foundation Trust.
Designed by architects Sheppard Robson, and aimed at health and medical technology companies, the scheme will provide high-specification, flexible office, laboratory, and clinical space. It is located in Manchester’s innovation district, Corridor Manchester, which has enterprise zone status, meaning occupiers can access significantly reduced business rates and super-fast connectivity.
The development of Citylabs 2.0 and 3.0 will be the first to be delivered under a strategic property partnership between CMFT, Bruntwood and Manchester Science Partnerships. Announced in March 2016, the partnership supports the strategic development of CMFT’s estate to deliver leading edge clinical care, research and innovation.
Phase one, the £25m Citylabs 2.0, is all new-build and will comprise 92,000 sq ft of Grade-A lab and office space. Construction work will begin late 2017, with completion expected in 2019.
Phase 2, Citylabs 3.0, will span 128,000 sq ft and integrate the development of new buildings with the Old Saint Mary’s Hospital, a listed Victorian building. Construction is due to be completed in late 2021.
The £35m project includes the restoration of an unused former chapel on the site, which will be transformed into a café/dining area with the potential for meeting room facilities.
The scheme also includes external landscaping and the provision of new gardens for the enjoyment of Citylabs customers, patients and hospital visitors. It comprises both new build and redevelopment of the Old Saint Mary’s Hospital building on the corner of Oxford Road and Hathersage Road.
Deloitte Real Estate advised Bruntwood and Manchester Science Partnerships on the planning application.
To send feedback, e-mail Louisa.Clarence-Smith@egi.co.uk or tweet @LouisaClarence or @estatesgazette
